Acute nose-only exposure of rats to phosgene. Part II. Concentration x time dependence of changes in bronchoalveolar lavage during a follow-up period of 3 months

Inhalation Toxicology

Volumn 18, Issue 9, 2006, Pages 595-607

  Pauluhn, Jürgen ^a,b  

^a BAYER PHARMA AG   (Germany)

^b Institute of Toxicology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; PHOSGENE; PHOSPHOLIPID; PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CELL INFILTRATION; CONTROLLED STUDY; EXPOSURE; FOLLOW UP; GAS FLOW; HISTOPATHOLOGY; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LUNG WEIGHT; MALE; MEASUREMENT; MORTALITY; NEUTROPHIL COUNT; NONHUMAN; NOSE MUCOSA; PERMEABILITY; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ALKALINE PHOSPHATASE; ANIMALS; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CAPILLARY PERMEABILITY; CELL COUNT; CHEMICAL WARFARE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INHALATION EXPOSURE; L-LACTATE DEHYDROGENASE; LUNG; MACROPHAGES, ALVEOLAR; MALE; NEUTROPHILS; ORGAN SIZE; PHOSGENE; PHOSPHOLIPIDS; PULMONARY ALVEOLI; RATS; RATS, WISTAR;

RATTUS NORVEGICUS;

EID: 33645312860     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.1080/08958370600742771     Document Type: Article

References (48)

1. Bide, R. W., Armour, S. J., and Yee, E. 2000. Allometric respiration/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans. J. Appl. Toxicol. 20:273-290.
2. Chan, A., Berry, L., O'Brodovich, H., Klement, P., Mitchell, L., Baranowski, B., Monagle, P., and Andrew, M. 1997. Covalent antithrombin-heparin complexes with high anticoagulant activity. J. Biol. Chem. 272:22111-22117.
3. Cucinell, S. A., and Edgewood, A. 1974. Review of the toxicity of long-term phosgene exposure. Arch. Environ. Health 28:272-275.
4. Currie, W. D., Pratt, P. C., and Frosolono, M. F. 1985. Response of pulmonary energy metabolism to phosgene. Toxicol. Ind. Health 1(2):17-27.
5. Currie, W. D., Hatch, G. E., and Frosolono, M. F. 1987. Pulmonary alterations in rats due to acute phosgene inhalation. Fundam. Appl. Toxicol. 8:107-114.
6. Doyle, I. R., Nicholas, T. E., and Bersten, A. D. 1999. Partitioning lung and plasma protein: Circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin. Exp. Pharmacol. Physiol. 26:185-197.
7. Duniho, S. M., Martin, J., Forster, J. S., Cascio, M. B., Moran, T. S., Carpin, L. B., and Sciuto, A. M. 2001. Acute pulmonary changes in mice exposed to phosgene. Toxicol. Pathol. 30:339-349.
8. European Community. 1986. Directive 86/609/EEC. Guideline of the Council dated November 24, 1986 on the reconciliation of legal and administrative regulations of the member countries for the protection of animals used for studies and other scientific purposes. J. Eur. Commun. Legal Spec. L358 29:1-28.
9. Franch, S., and Hatch, G. E. 1986. Pulmonary biochemical effects of inhaled phosgene in rats. J. Toxicol. Environ. Health 19:413-423.
10. Frosolono, M. F., and Currie, W. D. 1985. Response of the pulmonary surfactant system to phosgene. Toxicol. Ind. Health 1:29-35.
11. Frosolono, M. F., and Pawlowski, R. 1977. Effect of phosgene on rat lungs after single high-level exposure: I. Biochemical alterations. Arch. Environ. Health 32: 271-277.
12. Ghio, A. J., and Hatch, G. E. 1996. Tolerance to phosgene is associated with a neutrophilic influx into the rat lung. Am. J. Respir. Crit. Care Med. 153:1064-1071.
13. Gregory A. R. 1970. Inhalation toxicology and lung edema receptor sites. Am. Ind. Hyg. Assoc. J. July-August:454-459.
14. Gross, P., Rinehart, W. E., and Hatch, T. 1965. Chronic pneumonitis caused by phosgene. Arch. Environ. Health 10:768-775.
15. Günther, A., Lübke, N., Ermert, M., Schermuly, R. T., Weissmann, N., Breithecker, A., Markart, P., Ruppert, C., Quanz, K., Ermert, L., Grimminger, F., and Seeger, W. 2003. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am. J. Respir. Crit. Care Med. 168:1358-1365.
16. Hatch, G. E., Kodavanti, U., Crissman, K., Slade, R., and Costa, D. 2001. An "injury-time integral" model for extrapolating from acute to chronic effects of phosgene. Toxicol. Ind. Health 17:285-293.
17. Jugg, B., Jenner, J., and Rice, P. 1999. The effect of perfluoroisobutene and phosgene on rat lavage fluid surfactant phospholipids. Hum. Exp. Toxicol. 18:659-668.
18. Jugg, B., Jenner, J., Hughes, J. N., and Rice, P. 2001. The effect of hexafluorocyclobutene on rat bronchoalveolar lavage fluid surfactant phospholipids and alveolar type II cells. Hum. Exp. Toxicol. 20:267-276.
19. Kodavanti, U. P., Costa, D. L., Giri, S. N., Starcher, B., and Hatch, G. E. 1997. Pulmonary structural and extracellular matrix alterations in Fischer 344 rats following subchronic exposure. Fundam. Appl. Toxicol. 37:54-63.
20. Malkusch, W., Rehn, B., and Bruch, J. 1995. Advantages of Sirius red staining for quantitative morphometric collagen measurements in lungs. Exp. Lung Res. 21:67-77.
21. Matthay, M. A., Folkesson, H. G., Campagna, A., and Kheradmand, F. 1993. Alveolar epithelial barrier and acute lung injury. N. Horizons 1:613-622.
22. Mauderly, J. L. 1986. Respiration of F344 Rats in nose-only Inhalation exposure tubes. J. Appl. Toxicol. 6:25-30.
23. Mautone, A. J., Katz, Z., and Scarpelli, E. M. 1985. Acute responses to phosgene inhalation and selected corrective measures (including surfactant). Toxicol. Ind. Health 1:37-57.
24. Office of Prevention, Pesticides and Toxic Substances. 1988. US EPA Health Effects Test Guidelines 870.1300 - Acute inhalation toxicity. Washington, DC: U.S. Environmental Protection Agency, OPPTS 870.1300. EPA 712C-98-193. August.
25. Organization for Economic Cooperation and Development. 1981. Guideline for testing of chemicals No. 403. Acute inhalation toxicity. Adopted May 12. OECD. (1981). Available: [http://www.oecd.org/document/22/0,2340, en_2649_34377_1916054_1_1_1_1,00.html]
26. Organization for Economic Cooperation and Development. 1983. [German version of the OECD Principles of Good Laboratory Practice (GLP).] Bundesanzeiger 35(42a).
27. Parker, J. C., and Townsley, M. I. 2004. Evaluation of lung injury in rats and mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L231-L246.
28. Pauluhn, J. 2000a. Acute inhalation toxicity of polymeric diphenylmethane-4,4′-diisocyanate (MDI) in rats: Time course of changes in bronchoalveolar lavage. Arch. Toxicol. 74:257-269.
29. Pauluhn, J. 2000b. Inhalation toxicity of 1,6-hexamethylene diisocyanate-homopolymer (HDI-IC) aerosol: Results of single inhalation exposure studies. Toxicol. Sci. 58:173-181.
30. Pauluhn, J. 2002. Short-term inhalation toxicity of polyisocyanate aerosols in rats: Comparative assessment of irritant-threshold concentrations by bronchoalveolar lavage. Inhal. Toxicol. 14:287-301.
31. Pauluhn, J. 2004a. Acute inhalation studies with irritant aerosols: Technical issues and relevance for risk characterization. Arch. Toxicol. 78:243-251.
32. Pauluhn, J. 2004b. Comparative analysis of pulmonary irritation by measurements of Penh and protein in bronchoalveolar lavage fluid in Brown Norway rats and Wistar rats exposed to irritant aerosols. Inhal. Toxicol. 16:159-175.
33. Pauluhn, J. 2004c. Pulmonary irritant potency of polyisocyanate aerosols in rats: Comparative assessment of irritant-threshold concentrations by bronchoalveolar lavage. J. Appl. Toxicol. 24:231-247.
34. Pauluhn, J. 2005. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: Time-course and dose-response of biomarkers of exposure and effect. Toxicology 207:59-72.
35. 50s and nonlethal threshold concentrations and analysis of breathing patterns. Inhal. Toxicol. 18:423-435.
36. Pauluhn, J., and Mohr, U. 2000. Inhalation studies in laboratory animals - Current concepts and alternatives. Review. Toxicol. Pathol. 28:734-753.
37. Pawlowski, R., and Frosolono, M. F. 1977. Effect of phosgene on rat lungs after single high-level exposure. II. Ultrastructural alternations. Arch. Environ. Health 32:278-283.
38. Rinehart, W. E., and Hatch, T. 1964. Concentration-time product (CT) as an expression of dose in sublethal exposures to phosgene. Am. Ind. Hyg. Assoc. J. 25:545-553.
39. Ruppert, C., Markart, P., Schmidt, R., Grimminger, F., Seeger,W., Lehr, C.-M., and Günther, A. 2003. Chemical crosslinking of urokinase to pulmonary surfactant protein B for targeting alveolar fibrin. Thromb. Haemost. 89:53-64.
40. Sciuto, A. M. 1998. Assessment of acute lung injury in rodents exposed to phosgene. Arch. Toxicol. 72:283-288.
41. Sciuto, A. M., Moran, T. S., Narula, A., and Forster, J. S. 2001. Disruption of gas exchange in mice following exposure to the chemical threat agent phosgene. Mil. Med. 166:809-814.
42. Sciuto, A. M., Lee, R. B., Forster, J. S., Cascio, M. B., Clapp, D. L., and Moran, T. S. 2002. Temporal changes in respiratory dynamics in mice exposed to phosgene. Inhal. Toxicol. 14:487-501.
43. Sciuto, A. M., Cascio, M. B., Moran, T. S., and Forster, J. S. 2003. The fate of antioxidant enzymes in bronchoalveolar lavage fluid over 7 days in mice with acute lung injury.Inhal. Toxicol. 15:675-683.
44. Seeger, W., Stöhr, G., Wolf, H. R. D., and Neuhof, H. 1985. Alteration in surfactant function due to protein leakage: Special interaction with fibrin monomer. J. Appl. Physiol. 58:326-338.
45. Sokal, R. R., and Rohlf, P. J. 1969. The arcsin transformation. In Biometry, pp. 386-387. San Francisco: W. H. Freeman.
46. van Helden, H. P. M., van de Meent, D., Oostdijk, J. P., Joosen, M. J. A., van Esch, J. H. M., and Hammer, A. H. 2004. Protection of rats against perfluoroisobutene (PFIB)-induced pulmonary edema by curosurf and N-acetylcysteine. Inhal. Toxicol. 16:549-564.
47. Vijayaraghavan, R., Schaper, M., Thompson, R., Stock, M. F., and Alarie, Y. 1993. Characteristic modifications of the breathing pattern of mice to evaluate the effects of airborne chemicals on the respiratory tract. Arch. Toxicol. 67:478-490
48. Zwart, A., Arts, J. H. E., Klokman-Houweling, J. M., and Schoen, E. D. 1990. Determination of concentration-time-mortality relationships to replace LC50 values. Inhal. Toxicol. 2:105-117.